Table 2. Detailed data of patients included in the study.
| Patient number | Age/Sex | Under the rubble time (hour) | Bone fracture | Fasciotomy extremity | MESS score | HBOT (hour) | Amputation level before HBOT | Amputation level after HBOT |
| 1 | 28/M | 7 | Lower | 8 | 36 | Transfemoral | Transfemoral | |
| 2 | 39/M | 9 | Lower | 10 | 22 | Transtibial | Transtibial | |
| 3 | 17/F | 11 | Forearm | Upper | 11 | 34 | Transhumeral | Transhumeral |
| 4 | 41/M | 8 | Lower | 9 | 28 | Transfemoral | Transfemoral | |
| 5 | 37/M | 7 | Upper | 8 | 38 | Transhumeral | Transradial | |
| 6 | 59/F | 22 | Femur | Lower | 9 | 30 | Hip disarticulation | Hip disarticulation |
| 7 | 49/F | 11 | Upper | 10 | 28 | Transradial | Transradial | |
| 8 | 47/M | 6 | Lower | 11 | 14 | Transfemoral | Transfemoral | |
| 9 | 23/M | 9 | Lower | 12 | 18 | Transfemoral | Transfemoral | |
| 10 | 18/M | 10 | Lower | 11 | 20 | Transfemoral | Transfemoral | |
| 11 | 56/F | 21 | Forearm | Upper | 7 | 18 | Transhumeral | Transhumeral |
| 12 | 33/M | 19 | Lower | 10 | 20 | Transfemoral | Transfemoral | |
| 13 | 24/M | 9 | Lower | 10 | 14 | Transfemoral | Transfemoral | |
| 14 | 48/F | 8 | Lower | 11 | 60 | Transtibial | Transtibial | |
| 15 | 51/M | 10 | Tibia | Lower | 12 | 32 | Transfemoral | Transfemoral |
| 16 | 22/F | 23 | Lower | 10 | 18 | Transfemoral | Transfemoral | |
| 17 | 27/F | 7 | Lower | 9 | 20 | Transtibial | Transtibial | |
| 18 | 64/M | 9 | Lower | 10 | 22 | Transfemoral | Transfemoral | |
| 19 | 39/F | 20 | Tibia | Lower | 8 | 42 | Transfemoral | Transfemoral |
| 20 | 31/M | 13 | Lower | 10 | 16 | Transtibial | Transtibial | |
| 21 | 27/M | 14 | Ankle | Lower | 11 | 20 | Transtibial | Transtibial |
| 22 | 35/F | 18 | Lower | 10 | 28 | Transfemoral | Transfemoral | |
| 23 | 31/M | 12 | Lower | 12 | 32 | Transfemoral | Transfemoral | |
| MESS: Mangled Extremity Severity Score; HBOT: Hyperbaric oxygen therapy. | ||||||||